BiotechTube
Home/BCN Biosciences/Andrew J. Norris
AJ

Andrew J. Norris

Co-founder & Director of Research

BCN Biosciences

Therapeutic Areas

Oncology

BCN Biosciences Pipeline

DrugIndicationPhase
RAS Pathway Inhibitor (PTEN restoration)KRAS-mutant cancers (G12D, G12V variants)Preclinical
PD-1 Expression InhibitorImmuno-oncologyPreclinical

Leadership Team at BCN Biosciences

SC
Sudip Chakrabortty
Co-founder & CEO
View full BCN Biosciences profile